|
US5939262A
(en)
*
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
|
DE19737442C2
(de)
*
|
1997-08-22 |
1999-06-24 |
Olfert Landt Tib Molbiol Synth |
Proteinumhüllte Polyribonukleinsäuren, ein Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
EP1892299A3
(en)
*
|
1997-09-19 |
2011-07-20 |
Life Technologies Corporation |
Sense mRNA therapy
|
|
US20030083272A1
(en)
*
|
1997-09-19 |
2003-05-01 |
Lahive & Cockfield, Llp |
Sense mrna therapy
|
|
US7767422B2
(en)
*
|
1998-09-22 |
2010-08-03 |
Oncomedx, Inc. |
Detection of 5T4 RNA in plasma and serum
|
|
US6777210B1
(en)
*
|
1998-09-24 |
2004-08-17 |
Ambion, Inc. |
Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1
|
|
DE19956568A1
(de)
*
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
KR20000065690A
(ko)
*
|
1999-04-08 |
2000-11-15 |
박종구 |
반응 특이성 및 안정성을 개선시킨 안티센스 올리고 뉴클레오타이드, 안티센스 ｄｎａ 및 그 제조방법
|
|
US7829693B2
(en)
*
|
1999-11-24 |
2010-11-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
|
ES2253358T3
(es)
*
|
2000-03-31 |
2006-06-01 |
Cambridge Antibody Technology Limited |
Mejoras en la visualizacion del ribosoma.
|
|
EP1354060B1
(en)
*
|
2000-08-28 |
2011-02-09 |
Oncomedx, Inc. |
5t4 rna in plasma and serum as a marker for neoplastic disease
|
|
GB0021303D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Medinnova Sf |
Use
|
|
RU2189396C2
(ru)
*
|
2000-10-27 |
2002-09-20 |
Федеральное государственное учреждение науки и здравоохранения Нижегородский научно-исследовательский институт эпидемиологии и микробиологии им. акад. И.Н.Блохиной |
Способ обнаружения и дифференциации рнк энтеровирусов
|
|
US8546143B2
(en)
|
2001-01-09 |
2013-10-01 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
|
US20020172972A1
(en)
*
|
2001-05-15 |
2002-11-21 |
President And Fellows Of Harvard College |
Use of a selectively inactivatable enzyme to digest contaminating nucleic acid
|
|
CN1311084C
(zh)
*
|
2001-12-06 |
2007-04-18 |
阿隆戴蒙德艾滋病研究中心 |
利用嵌合噬菌体标准物的高灵敏基因组检测
|
|
EP2290098A1
(en)
|
2002-01-28 |
2011-03-02 |
Ambion, Inc. |
Preparing crude biological extracts using protease, suitable for preparing cDNA
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
EP2213737B1
(en)
|
2002-02-01 |
2012-11-07 |
Life Technologies Corporation |
Double-stranded oligonucleotides
|
|
US7482116B2
(en)
|
2002-06-07 |
2009-01-27 |
Dna Genotek Inc. |
Compositions and methods for obtaining nucleic acids from sputum
|
|
WO2003103605A2
(en)
*
|
2002-06-07 |
2003-12-18 |
Large Scale Biology Corporation |
Flexible vaccine assembly and vaccine delivery platform
|
|
WO2004085611A2
(en)
*
|
2003-03-21 |
2004-10-07 |
The Research Foundation Of State University Of New York |
Model for mutually exclusive domain folding molecular switch
|
|
DE602004030114D1
(de)
*
|
2003-05-20 |
2010-12-30 |
Investigen Inc |
System zum nachweis von polynukleotiden
|
|
US7173015B2
(en)
|
2003-07-03 |
2007-02-06 |
The Trustees Of The University Of Pennsylvania |
Inhibition of Syk kinase expression
|
|
DE602004026912D1
(de)
*
|
2003-12-16 |
2010-06-10 |
Qiagen North American Holdings |
Formulierungen und verfahren zum denaturieren von proteinen
|
|
WO2005097817A2
(en)
*
|
2004-04-05 |
2005-10-20 |
Alnylam Pharmaceuticals, Inc. |
Process and reagents for oligonucleotide synthesis and purification
|
|
AU2005325262B2
(en)
|
2004-04-27 |
2011-08-11 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
|
|
US7674778B2
(en)
*
|
2004-04-30 |
2010-03-09 |
Alnylam Pharmaceuticals |
Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine
|
|
CA2572151A1
(en)
|
2004-06-30 |
2006-08-24 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a non-phosphate backbone linkage
|
|
AU2005328382C1
(en)
|
2004-07-21 |
2013-01-24 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
|
CA2574603C
(en)
|
2004-08-04 |
2014-11-04 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
|
|
US7309589B2
(en)
|
2004-08-20 |
2007-12-18 |
Vironix Llc |
Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
|
|
EP2309269B1
(en)
|
2004-09-08 |
2016-10-26 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Compositions and methods for the detection of HIV-1/HIV-2 infection.
|
|
WO2006045591A2
(en)
*
|
2004-10-25 |
2006-05-04 |
Devgen N.V. |
Method and constructs for delivering double stranded rna to pest organisms
|
|
JP5390772B2
(ja)
|
2004-11-05 |
2014-01-15 |
キアゲン ノース アメリカン ホールディングス， インコーポレイテッド |
核酸を安定化試薬から精製するための組成物および方法
|
|
JP2009501531A
(ja)
*
|
2005-07-15 |
2009-01-22 |
アプレラ コーポレイション |
Ｒｎａプロファイリングのための方法
|
|
WO2007100711A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
US20100099149A1
(en)
|
2006-10-06 |
2010-04-22 |
Dna Genotek Inc. |
Stabilizing compositions and methods for extraction of ribonucleic acid
|
|
WO2008051817A1
(en)
*
|
2006-10-20 |
2008-05-02 |
Novartis Ag |
Compositions and method for monitoring bcr-abl expression
|
|
US20080096193A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Charles Robert Bupp |
Methods and compositions for detecting polynucleotides
|
|
CN101173252B
(zh)
*
|
2006-10-31 |
2011-09-21 |
杭州市疾病预防控制中心 |
披甲rna及其制备方法
|
|
WO2008103702A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Investigen, Inc. |
Methods and compositions for rapid light-activated isolation and detection of analytes
|
|
US7964350B1
(en)
|
2007-05-18 |
2011-06-21 |
Applied Biosystems, Llc |
Sample preparation for in situ nucleic acid analysis
|
|
WO2009151697A2
(en)
*
|
2008-03-14 |
2009-12-17 |
The Government Of United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and processes relating to human bocavirus
|
|
US8324149B2
(en)
*
|
2008-11-18 |
2012-12-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Encapsidation of heterologous entities into virus-like particles
|
|
US20100129902A1
(en)
|
2008-11-24 |
2010-05-27 |
Erhard Ralf Schoenbrunner |
Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
|
|
EP2367954B1
(en)
*
|
2008-12-19 |
2015-02-18 |
Life Technologies Corporation |
Proteinase k inhibitors, methods and compositions therefor
|
|
JP6121591B2
(ja)
*
|
2010-07-29 |
2017-04-26 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
微生物核酸の定性的および定量的検出
|
|
US8877464B2
(en)
|
2010-07-29 |
2014-11-04 |
Roche Molecular Systems, Inc. |
Qualitative and quantitative detection of microbial nucleic acids
|
|
CN103154269A
(zh)
|
2010-07-29 |
2013-06-12 |
霍夫曼-拉罗奇有限公司 |
用于多种参数的对照核酸
|
|
CN103025891A
(zh)
|
2010-07-29 |
2013-04-03 |
霍夫曼-拉罗奇有限公司 |
通用样品制备
|
|
ES2605303T3
(es)
*
|
2010-07-29 |
2017-03-13 |
F. Hoffmann-La Roche Ag |
Detección cualitativa y cuantitativa de ácidos nucleicos microbianos
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2426222A1
(en)
|
2010-09-07 |
2012-03-07 |
F. Hoffmann-La Roche AG |
Generic buffer for amplification
|
|
RU2013120302A
(ru)
|
2010-10-01 |
2014-11-20 |
Модерна Терапьютикс, Инк. |
Сконструированные нуклеиновые кислоты и способы их применения
|
|
EP2465945A1
(en)
|
2010-12-17 |
2012-06-20 |
F. Hoffmann-La Roche AG |
Generic matrix for control nucleic acids
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
CN106442039B
(zh)
|
2011-06-19 |
2020-08-07 |
阿博根公司 |
用于样品采集的装置、溶液和方法
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
EP2825639B1
(en)
|
2012-03-13 |
2017-10-25 |
EMD Millipore Corporation |
Use of centrifugation-aided infection to increase virus titer
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
WO2014081507A1
(en)
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
US9481903B2
(en)
|
2013-03-13 |
2016-11-01 |
Roche Molecular Systems, Inc. |
Systems and methods for detection of cells using engineered transduction particles
|
|
KR102127358B1
(ko)
|
2013-03-13 |
2020-06-29 |
지니위브 바이오사이언시스, 인코포레이티드 |
비-복제 형질도입 입자 및 형질도입 입자-기반 리포터 시스템
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
JP2016538829A
(ja)
|
2013-10-03 |
2016-12-15 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
低密度リポタンパク質受容体をコードするポリヌクレオチド
|
|
US9540675B2
(en)
|
2013-10-29 |
2017-01-10 |
GeneWeave Biosciences, Inc. |
Reagent cartridge and methods for detection of cells
|
|
EP3105343A1
(en)
*
|
2014-02-10 |
2016-12-21 |
AmpTec GmbH |
Incoated rna
|
|
SG10201912038TA
(en)
|
2014-04-23 |
2020-02-27 |
Modernatx Inc |
Nucleic acid vaccines
|
|
GB201412316D0
(en)
*
|
2014-07-10 |
2014-08-27 |
Momentum Bioscience Ltd |
Detecting the absence of micro-organisms
|
|
JP6822974B2
(ja)
|
2015-05-29 |
2021-01-27 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
シトラコン酸無水物によって微生物を不活性化する方法
|
|
US10351893B2
(en)
|
2015-10-05 |
2019-07-16 |
GeneWeave Biosciences, Inc. |
Reagent cartridge for detection of cells
|
|
US20180320199A1
(en)
|
2015-10-28 |
2018-11-08 |
Life Science Inkubator Gmbh |
Use of vlp for the detection of nucleic acids
|
|
US10689689B2
(en)
*
|
2015-12-28 |
2020-06-23 |
Roche Molecular Systems, Inc. |
Generic method for the stabilization of specific RNA
|
|
US20170356025A1
(en)
|
2016-06-14 |
2017-12-14 |
Roche Molecular Systems, Inc. |
Internal control probes for improving pcr assay performance
|
|
EP3299471B1
(en)
|
2016-09-23 |
2019-10-23 |
Roche Diagniostics GmbH |
Methods for determining the amount of a nucleic acid of interest in an unprocessed sample
|
|
US10422012B2
(en)
|
2016-10-10 |
2019-09-24 |
Roche Molecular Systems, Inc. |
Devices comprising bacteriophage PHI6 internal control compositions
|
|
ES2944360T3
(es)
|
2017-10-03 |
2023-06-20 |
Abbott Molecular Inc |
Ensayo para la detección del virus de la inmunodeficiencia humana (VIH)
|
|
CN110892082A
(zh)
|
2017-10-03 |
2020-03-17 |
雅培分子公司 |
丙型肝炎病毒(hcv)的测定
|
|
WO2019139792A1
(en)
|
2018-01-09 |
2019-07-18 |
Abbott Molecular Inc. |
Assay for detecting chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis, and mycoplasma genitalium
|
|
WO2022045009A1
(ja)
*
|
2020-08-24 |
2022-03-03 |
国立大学法人山口大学 |
流体を追跡するための組成物及び流体の追跡方法
|
|
CN115896243A
(zh)
*
|
2022-11-25 |
2023-04-04 |
上海厦维医学检验实验室有限公司 |
基于混合酶体系的超灵敏反转录方法及其应用
|